MicroRNA in pancreatic cancer

Journal of Human Genetics

Volumn 62, Issue 1, 2017, Pages 33-40

  Yonemori, Keiichi ^a   Kurahara, Hiroshi ^a   Maemura, Kosei ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA; JANUS KINASE; K RAS PROTEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; MESSENGER RNA;

APOPTOSIS; CANCER PATIENT; CANCER RESISTANCE; CANCER TISSUE; CELL CYCLE; CELL PROLIFERATION; DNA METHYLATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; METASTASIS; NONHUMAN; PANCREAS CANCER; PANCREAS TISSUE; REVIEW; RNA ANALYSIS; TUMOR GROWTH; WNT SIGNALING PATHWAY; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

CARCINOMA, PANCREATIC DUCTAL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 85008711806     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2016.59     Document Type: Review

References (130)

1. Yu, J., Ohuchida, K., Mizumoto, K., Fujita, H., Nakata, K. & Tanaka, M. MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol. Ther. 10, 748-757 (2010).
2. Chrystoja, C. C., Diamandis, E. P., Brand, R., Ruckert, F., Haun, R. & Molina, R. Pancreatic cancer. Clin. Chem. 59, 41-46 (2013).
3. Matsuno, S., Egawa, S., Fukuyama, S., Motoi, F., Sunamura, M., Isaji, S. et al. Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 28, 219-230 (2004).
4. Dhayat, S. A., Mardin, W. A., Seggewiss, J., Strose, A. J., Matuszcak, C., Hummel, R. et al. MicroRNA profiling implies new markers of gemcitabine chemoresistance in mutant p53 pancreatic ductal adenocarcinoma. PLoS ONE 10, e0143755 (2015).
5. Bournet, B., Buscail, C., Muscari, F., Cordelier, P. & Buscail, L. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities. Eur. J. Cancer 54, 75-83 (2016).
6. Chiorean, E. G. & Coveler, A. L. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies. Drug Des. Devel. Ther. 9, 3529-3545 (2015).
7. Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10, 704-714 (2009).
8. Mi, S., Zhang, J., Zhang, W. & Huang, R. S. Circulating microRNAs as biomarkers for inflammatory diseases. Microrna 2, 63-71 (2013).
9. Slack, F. J. & Weidhaas, J. B. MicroRNA in cancer prognosis. N. Engl. J. Med. 359, 2720-2722 (2008).
10. Sun, X., Zhang, Y., Zhu, X., Korir, N. K., Tao, R., Wang, C. et al. Advances in identification and validation of plant microRNAs and their target genes. Physiol. Plant 152, 203-218 (2014).
11. Szafranska, A. E., Davison, T. S., John, J., Cannon, T., Sipos, B., Maghnouj, A. et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26, 4442-4452 (2007).
12. Bloomston, M., Frankel, W. L., Petrocca, F., Volinia, S., Alder, H., Hagan, J. P. et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901-1908 (2007).
13. Jamieson, N. B., Morran, D. C., Morton, J. P., Ali, A., Dickson, E. J., Carter, C. R. et al. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin. Cancer Res. 18, 534-545 (2012).
14. Nagao, Y., Hisaoka, M., Matsuyama, A., Kanemitsu, S., Hamada, T., Fukuyama, T. et al. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod. Pathol. 25, 112-121 (2012).
15. Piepoli, A., Tavano, F., Copetti, M., Mazza, T., Palumbo, O., Panza, A. et al. Mirna expression profiles identify drivers in colorectal and pancreatic cancers. PLoS ONE 7, e33663 (2012).
16. Bauer, A. S., Keller, A., Costello, E., Greenhalf, W., Bier, M., Borries, A. et al. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS ONE 7, e34151 (2012).
17. Ali, S., Saleh, H., Sethi, S., Sarkar, F. H. & Philip, P. A. MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br. J. Cancer 107, 1354-1360 (2012).
18. Zhang, S., Hao, J., Xie, F., Hu, X., Liu, C., Tong, J. et al. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogen-esis 32, 1183-1189 (2011).
19. Schultz, N. A., Werner, J., Willenbrock, H., Roslind, A., Giese, N., Horn, T. et al. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod. Pathol. 25, 1609-1622 (2012).
20. Hong, T. H. & Park, I. Y. MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens. Ann. Surg. Treat. Res 87, 290-297 (2014).
21. Hou, B. H., Jian, Z. X., Cui, P., Li, S. J., Tian, R. Q. & Ou, J. R. miR-216a may inhibit pancreatic tumour growth by targeting JAK2. FEBS Lett. 589, 2224-2232 (2015).
22. Furukawa, T. Impacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancer. Front. Oncol. 5, 23 (2015).
23. Ryan, D. P., Hong, T. S. & Bardeesy, N. Pancreatic adenocarcinoma. N. Engl. J. Med. 371, 1039-1049 (2014).
24. Eser, S., Schnieke, A., Schneider, G. & Saur, D. Oncogenic KRAS signalling in pancreatic cancer. Br. J. Cancer. 111, 817-822 (2014).
25. Zhao, W. G., Yu, S. N., Lu, Z. H., Ma, Y. H., Gu, Y. M. & Chen, J. The miR-217 microRNA functions as a potential tumour suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31, 1726-1733 (2010).
26. Ma, Y., Yu, S., Zhao, W., Lu, Z. & Chen, J. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett. 298, 150-158 (2010).
27. Kent, O. A., Chivukula, R. R., Mullendore, M., Wentzel, E. A., Feldmann, G., Lee, K. H. et al. Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumour-promoting feed-forward pathway. Genes Dev. 24, 2754-2759 (2010).
28. Ferro, R. & Falasca, M. Emerging role of the KRAS-PDK1 axis in pancreatic cancer. World J. Gastroenterol. 20, 10752-10757 (2014).
29. Song, M. S., Salmena, L. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 (2012).
30. Park, J. K., Lee, E. J., Esau, C. & Schmittgen, T. D. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 38, e190-e199 (2009).
31. Sarkar, S., Dubaybo, H., Ali, S., Goncalves, P., Kollepara, S. L., Sethi, S. et al. Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Am. J. Cancer Res. 3, 465-477 (2013).
32. Liu, J., Xu, D., Wang, Q., Zheng, D., Jiang, X. & Xu, L. LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4. Dig. Dis. Sci. 59, 1452-1460 (2014).
33. Zhou, J., Song, S., He, S., Zhu, X., Zhang, Y., Yi, B. et al. MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signalling pathway. Int. J. Mol. Med. 33, 950-956 (2014).
34. Song, S. D., Zhou, J., Zhou, J., Zhao, H., Cen, J. N. & Li, D. C. MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma. Oncol. Lett. 6, 953-959 (2013).
35. Li, Y., VandenBoom, T. G. 2nd, Kong, D., Wang, Z., Ali, S., Philip, P. A. et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 69, 6704-6712 (2009).
36. Yu, J., Ohuchida, K., Mizumoto, K., Sato, N., Kayashima, T., Fujita, H. et al. MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol. Cancer. 9, 169 (2010).
37. Radhakrishnan, P., Mohr, A. M., Grandgenett, P. M., Steele, M. M., Batra, S. K. & Hollingsworth, M. A. MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer. PLoS ONE 8, e73356 (2013).
38. Rachagani, S., Macha, M. A., Ponnusamy, M. P., Haridas, D., Kaur, S., Jain, M. et al. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis 33, 1953-1964 (2012).
39. Kaur, S., Sharma, N., Krishn, S. R., Lakshmanan, I., Rachagani, S., Baine, M. J. et al. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-kappaB signalling in pancreatic cancer. Clin. Cancer Res. 20, 688-700 (2014).
40. Rawlings, J. S., Rosler, K. M. & Harrison, D. A. The JAK/STAT signalling pathway. J. Cell Sci. 117, 1281-1283 (2004).
41. Harrison, D. A. The Jak/STAT pathway. Cold Spring Harb. Perspect. Biol 4 (2012).
42. Wang, S., Chen, X. & Tang, M. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2. Oncol. Rep. 32, 2824-2830 (2014).
43. Zhao, G., Zhang, J. G., Shi, Y., Qin, Q., Liu, Y., Wang, B. et al. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PLoS ONE 8, e73803 (2013).
44. Huang, C., Li, H., Wu, W., Jiang, T. & Qiu, Z. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signalling pathway through SOCS1. Oncol. Rep. 30, 1223-1230 (2013).
45. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-850 (2005).
46. Morris, J. P. t., Wang, S. C. & Hebrok, M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat. Rev. Cancer. 10, 683-695 (2010).
47. Jiang, J., Yu, C., Chen, M., Zhang, H., Tian, S. & Sun, C. Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype. Oncotarget 6, 2767-2778 (2015).
48. Listing, H., Mardin, W. A., Wohlfromm, S., Mees, S. T. & Haier, J. MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer. Br. J. Cancer. 112, 131-139 (2015).
49. Achyut, B. R. & Yang, L. Transforming growth factor-beta in the gastrointestinal and hepatic tumour microenvironment. Gastroenterology 141, 1167-1178 (2011).
50. Tian, M., Neil, J. R. & Schiemann, W. P. Transforming growth factor-beta and the hallmarks of cancer. Cell Signal. 23, 951-962 (2011).
51. Papageorgis, P. TGFbeta Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis. J. Oncol. 2015, 587193 (2015).
52. Derynck, R., Muthusamy, B. P. & Saeteurn, K. Y. Signaling pathway cooperation in TGF-beta-induced epithelial-mesenchymal transition. Curr. Opin. Cell Biol. 31, 56-66 (2014).
53. Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S. et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582-589 (2008).
54. Mohr, A. M., Bailey, J. M., Lewallen, M. E., Liu, X., Radhakrishnan, P., Yu, F. et al. MUC1 regulates expression of multiple microRNAs involved in pancreatic tumour progression, including the miR-200c/141 cluster. PLoS ONE 8, e73306 (2013).
55. Zhang, W. L., Zhang, J. H., Wu, X. Z., Yan, T. & Lv, W. miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer. Int. J. Oncol. 47, 1043-1053 (2015).
56. Santo, L., Siu, K. T. & Raje, N. Targeting Cyclin-dependent kinases and cell cycle progression in human cancers. Semin. Oncol. 42, 788-800 (2015).
57. Lee, K. H., Lotterman, C., Karikari, C., Omura, N., Feldmann, G., Habbe, N. et al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9, 293-301 (2009).
58. Deng, J., He, M., Chen, L., Chen, C., Zheng, J. & Cai, Z. The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival. PLoS ONE 8, e76450 (2013).
59. Ma, J., Fang, B., Zeng, F., Ma, C., Pang, H., Cheng, L. et al. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Oncotarget 6, 1740-1749 (2015).
60. Xu, W., Taranets, L. & Popov, N. Regulating Fbw7 on the road to cancer. Semin. Cancer Biol. 36, 62-70 (2016).
61. Starostina, N. G. & Kipreos, E. T. Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol. 22, 33-41 (2012).
62. Kitagawa, K., Kotake, Y. & Kitagawa, M. Ubiquitin-mediated control of oncogene and tumour suppressor gene products. Cancer Sci. 100, 1374-1381 (2009).
63. Zhao, Y., Wang, Y., Yang, Y., Liu, J., Song, Y., Cao, Y. et al. MicroRNA-222 controls human pancreatic cancer cell line capan-2 proliferation by P57 targeting. J. Cancer 6, 1230-1235 (2015).
64. Mihaylova, M. M. & Shaw, R. J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13, 1016-1023 (2011).
65. Zhao, G., Zhang, J. G., Liu, Y., Qin, Q., Wang, B., Tian, K. et al. miR-148b functions as a tumour suppressor in pancreatic cancer by targeting AMPKalpha1. Mol. Cancer Ther 12, 83-93 (2013).
66. Boutros, R., Lobjois, V. & Ducommun, B. CDC25 phosphatases in cancer cells: key players? Good targets? Nat. Rev. Cancer. 7, 495-507 (2007).
67. Liffers, S. T., Munding, J. B., Vogt, M., Kuhlmann, J. D., Verdoodt, B., Nambiar, S. et al. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcino-mas and regulates cell survival by targeting CDC25B. Lab. Invest. 91, 1472-1479 (2011).
68. Arlt, A., Muerkoster, S. S. & Schafer, H. Targeting apoptosis pathways in pancreatic cancer. Cancer Lett. 332, 346-358 (2013).
69. Fulda, S. Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. J. Cell. Mol. Med. 13, 1221-1227 (2009).
70. Dong, J., Zhao, Y. P., Zhou, L., Zhang, T. P. & Chen, G. Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells. Arch. Med. Res. 42, 8-14 (2011).
71. Liu, P., Liang, H., Xia, Q., Li, P., Kong, H., Lei, P. et al. Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression. Clin. Transl. Oncol. 15, 741-746 (2013).
72. Cai, B., An, Y., Lv, N., Chen, J., Tu, M., Sun, J. et al. miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. Oncol. Rep. 29, 1769-1776 (2013).
73. Bhatti, I., Lee, A., James, V., Hall, R. I., Lund, J. N., Tufarelli, C. et al. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J. Gastrointest. Surg. 15, 199-208 (2011).
74. Tomasini, R., Seux, M., Nowak, J., Bontemps, C., Carrier, A., Dagorn, J. C. et al. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 24, 8093-8104 (2005).
75. Gironella, M., Seux, M., Xie, M. J., Cano, C., Tomasini, R., Gommeaux, J. et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumour development. Proc. Natl Acad. Sci. USA. 104, 16170-16175 (2007).
76. Li, B., Sun, M., Gao, F., Liu, W., Yang, Y., Liu, H. et al. Up-regulated expression of miR-23a/b targeted the pro-apoptotic Fas in radiation-induced thymic lymphoma. Cell Physiol. Biochem. 32, 1729-1740 (2013).
77. Mi, S., Lu, J., Sun, M., Li, Z., Zhang, H., Neilly, M. B. et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukaemia from acute myeloid leukaemia. Proc. Natl Acad. Sci. USA 104, 19971-19976 (2007).
78. Gottardo, F., Liu, C. G., Ferracin, M., Calin, G. A., Fassan, M., Bassi, P. et al. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 25, 387-392 (2007).
79. Kozaki, K., Imoto, I., Mogi, S., Omura, K. & Inazawa, J. Exploration of tumour-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 68, 2094-2105 (2008).
80. Campioni, M., Santini, D., Tonini, G., Murace, R., Dragonetti, E., Spugnini, E. P. et al. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance. Exp. Dermatol. 14, 811-818 (2005).
81. Anichini, A., Mortarini, R., Sensi, M. & Zanon, M. APAF-1 signalling in human melanoma. Cancer Lett. 238, 168-179 (2006).
82. Liu, N., Sun, Y. Y., Zhang, X. W., Chen, S., Wang, Y., Zhang, Z. X. et al. Oncogenic miR-23a in pancreatic ductal adenocarcinogenesis via inhibiting APAF1. Dig. Dis. Sci. 60, 2000-2008 (2015).
83. Vousden, K. H. & Prives, C. Blinded by the light: the growing complexity of p53. Cell 137, 413-431 (2009).
84. Jafarnejad, S. M. & Li, G. Regulation of p53 by ING family members in suppression of tumour initiation and progression. Cancer Metastasis Rev. 31, 55-73 (2012).
85. Zhang, X. J., Ye, H., Zeng, C. W., He, B., Zhang, H. & Chen, Y. Q. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J. Hematol. Oncol. 3, 46 (2010).
86. Liu, M., Du, Y., Gao, J., Liu, J., Kong, X., Gong, Y. et al. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells. Pancreas 42, 1169-1181 (2013).
87. Sionov, R. V., Vlahopoulos, S. A. & Granot, Z. Regulation of bim in health and disease. Oncotarget 6, 23058-23134 (2015).
88. Liu, R., Zhang, H., Wang, X., Zhou, L., Li, H., Deng, T. et al. The miR-24-Bim pathway promotes tumour growth and angiogenesis in pancreatic carcinoma. Oncotarget 6, 43831-43842 (2015).
89. Gross, D. N., van den Heuvel, A. P. & Birnbaum, M. J. The role of FoxO in the regulation of metabolism. Oncogene 27, 2320-2336 (2008).
90. Song, W., Li, Q., Wang, L. & Wang, L. Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma. Cell Physiol. Biochem. 35, 184-190 (2015).
91. Wang, P., Zhu, C. F., Ma, M. Z., Chen, G., Song, M., Zeng, Z. L. et al. Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer. Oncotarget 6, 21148-21158 (2015).
92. Denis, H., Ndlovu, M. N. & Fuks, F. Regulation of mammalian DNA methyltrans-ferases: a route to new mechanisms. EMBO Rep. 12, 647-656 (2011).
93. Dhe-Paganon, S., Syeda, F. & Park, L. DNA methyl transferase 1: regulatory mechanisms and implications in health and disease. IInt. J. Biochem. Mol. Biol. 2, 58-66 (2011).
94. De Marzo, A. M., Marchi, V. L., Yang, E. S., Veeraswamy, R., Lin, X. & Nelson, W. G. Abnormal regulation of DNA methyltransferase expression during colorectal carcino-genesis. Cancer Res. 59, 3855-3860 (1999).
95. Azizi, M., Teimoori-Toolabi, L., Arzanani, M. K., Azadmanesh, K., Fard-Esfahani, P. & Zeinali, S. MicroRNA-148b and microRNA-152 reactivate tumour suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. Cancer Biol. Ther. 15, 419-427 (2014).
96. Moroishi, T., Hansen, C. G. & Guan, K. L. The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer 15, 73-79 (2015).
97. Zhu, Z. M., Xu, Y. F., Su, Q. J., Du, J. D., Tan, X. L., Tu, Y. L. et al. Prognostic significance of microRNA-141 expression and its tumour suppressor function in human pancreatic ductal adenocarcinoma. Mol. Cell Biochem. 388, 39-49 (2014).
98. Yuan, H., Su, L. & Chen, W. Y. The emerging and diverse roles of sirtuins in cancer: a clinical perspective. Onco. Targets Ther 6, 1399-1416 (2013).
99. Deng, S., Zhu, S., Wang, B., Li, X., Liu, Y., Qin, Q. et al. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Cancer Lett. 355, 184-191 (2014).
100. Zhao, G., Wang, B., Liu, Y., Zhang, J. G., Deng, S. C., Qin, Q. et al. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Mol. Cancer Ther 12, 2569-2580 (2013).
101. Xu, L., Li, Q., Xu, D., Wang, Q., An, Y., Du, Q. et al. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int. J. Oncol. 44, 459-466 (2014).
102. Zhan, Q., Fang, Y., Deng, X., Chen, H., Jin, J., Lu, X. et al. The interplay between miR-148a and DNMT1 might be exploited for pancreatic cancer therapy. Cancer Invest 33, 267-275 (2015).
103. Zhang, R., Li, M., Zang, W., Chen, X., Wang, Y., Li, P. et al. MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2. Tumour Biol. 35, 837-844 (2014).
104. Hanoun, N., Delpu, Y., Suriawinata, A. A., Bournet, B., Bureau, C., Selves, J. et al. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin. Chem. 56, 1107-1118 (2010).
105. Zhou, J., Song, S., Cen, J., Zhu, D., Li, D. & Zhang, Z. MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro. Oncology Res. 20, 197-203 (2012).
106. Lu, Y., Hu, J., Sun, W., Li, S., Deng, S. & Li, M. MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1. Onco. Targets Ther. 9, 99-109 (2016).
107. Zou, Y., Li, J., Chen, Z., Li, X., Zheng, S., Yi, D. et al. miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients. Carcinogenesis 36, 676-684 (2015).
108. Zhang, X., Shi, H., Lin, S., Ba, M. & Cui, S. MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy. Oncol. Rep. 34, 1557-1564 (2015).
109. Batchu, R. B., Gruzdyn, O. V., Qazi, A. M., Kaur, J., Mahmud, E. M., Weaver, D. W. et al. Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer. Surgery 158, 981-986; discussion 986-987 (2015).
110. Gao, L., Yang, Y., Xu, H., Liu, R., Li, D., Hong, H. et al. MiR-335 functions as a tumour suppressor in pancreatic cancer by targeting OCT4. Tumour Biol. 35, 8309-8318 (2014).
111. Hamada, S., Masamune, A., Miura, S., Satoh, K. & Shimosegawa, T. MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX. Cell Signal. 26, 179-185 (2014).
112. Wang, P., Zhuang, L., Zhang, J., Fan, J., Luo, J., Chen, H. et al. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL. Mol. Oncol 7, 334-345 (2013).
113. Liu, Q., Chen, J., Wang, J., Amos, C., Killary, A. M., Sen, S. et al. Putative tumour suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Mol. Carcinog. 53, 711-721 (2014).
114. Liu, W. J., Zhao, Y. P., Zhang, T. P., Zhou, L., Cui, Q. C., Zhou, W. X. et al. MLH1 as a direct target of MiR-155 and a potential predictor of favourable prognosis in pancreatic cancer. J. Gastrointest. Surg. 17, 1399-1405 (2013).
115. Li, Z., Li, X., Yu, C., Wang, M., Peng, F., Xiao, J. et al. MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3. Tumour Biol. 35, 11751-11759 (2014).
116. Xu, Q., Li, P., Chen, X., Zong, L., Jiang, Z., Nan, L. et al. miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases. Oncotarget 6, 14153-14164 (2015).
117. Laurila, E. M., Sandstrom, S., Rantanen, L. M., Autio, R. & Kallioniemi, A. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells. Genes Chromosomes Cancer 51, 557-568 (2012).
118. Ohuchida, K., Mizumoto, K., Lin, C., Yamaguchi, H., Ohtsuka, T., Sato, N. et al. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann. Surg. Oncol. 19, 2394-2402 (2012).
119. Hu, Y., Ou, Y., Wu, K., Chen, Y. & Sun, W. miR-143 inhibits the metastasis of pancreatic cancer and an associated signalling pathway. Tumour Biol. 33, 1863-1870 (2012).
120. Li, Y., VandenBoom, T. G. 2nd, Wang, Z., Kong, D., Ali, S., Philip, P. A. et al. Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells. Cancer Res. 70, 5703 (2010).
121. Ali, S., Ahmad, A., Aboukameel, A., Ahmed, A., Bao, B., Banerjee, S. et al. Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signalling. Cancer Lett. 351, 134-142 (2014).
122. Su, A., He, S., Tian, B., Hu, W. & Zhang, Z. MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells. PLoS ONE 8, e71309 (2013).
123. Gao, S., Wang, P., Hua, Y., Xi, H., Meng, Z., Liu, T. et al. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget 7, 1608-1618 (2016).
124. Khan, S., Ebeling, M. C., Zaman, M. S., Sikander, M., Yallapu, M. M., Chauhan, N. et al. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget 5, 7599-7609 (2014).
125. Srivastava, S. K., Bhardwaj, A., Singh, S., Arora, S., Wang, B., Grizzle, W. E. et al. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behaviour of pancreatic cancer cells. Carcinogenesis 32, 1832-1839 (2011).
126. Zhang, P., Guo, Z., Hu, R., He, X., Jiao, X. & Zhu, X. Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration. Tumour Biol. 36, 9693-9701 (2015).
127. Wang, P., Zhang, J., Zhang, L., Zhu, Z., Fan, J., Chen, L. et al. MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Gastroenterology 145, 1133-1143 e1112 (2013).
128. He, G., Zhang, L., Li, Q. & Yang, L. miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation. Biomed. Pharmacother. 68, 25-30 (2014).
129. Takiuchi, D., Eguchi, H., Nagano, H., Iwagami, Y., Tomimaru, Y., Wada, H. et al. Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells. Pancreatology 13, 517-523 (2013).
130. Huang, F., Tang, J., Zhuang, X., Zhuang, Y., Cheng, W., Chen, W. et al. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. PLoS ONE 9, e87897 (2014).